降糖明目胶囊治疗糖尿病视网膜病变临床观察VIP专享VIP免费

北京中医药大学学报第30卷第8期2007年8月JournalofBeijlngUniversityofTraditionalChineseMedicineV01．30No．8Aug．2007降糖明日胶囊治疗糖尿病视网膜病变临床观察8支楠1廉海红1马小丽1王津津2陈青红1何秀芹1鹿庆2(1首都医科犬学附属北京同仁医院传统医学科北京100730；2北京市眼科研究所)摘要：目的观察降糖明目胶囊治疗糖尿病性视网膜病变(DR)的临床疗效。方法选择60例DR患者作为治疗组，给予降糖明日腋囊治疗6个月后对治疗前后中医证候、血糖、安垒性等多种指标进行对比；同时选择60侧DR患者作为对照组，服用怡开6个月后与治疗组在眼底视网膜病变方面进行对比。结果治疗组可有效改善中医证候，治疗前后积分对比(P<0．01)；眼底视网膜病变的改善治疗组优于对照组(P<0．01)；治疗组血糖降低，治疗前后对比(P<0．01)；治疗组治疗前后安全性指标均有改善，且服药期间无明显不良反应。结论降糖明日胶囊可从整体上改善DR患者临床症状、改善眼底视网膜病变、降低血糖，并且有良好的安全性。关键词：糖尿病视网膜病变；降糖明日胶囊；滋补肝肾；活血化瘀中图分类号：1／276．774．1TreatmentofdiabeticretinopathywithJiangtangmingmuCapsulesZHINan，LIANHai-hong，MAXiao-li，eta1．(BeijingTongrenHospital，CapitalUniversityofMedicalSciences，Beijing100730)Abstract：ObjectiveToobservethecurativeeffectofJian粤angrningmuCapsules0ndiabeticretinopathy(DR)．MethodThetreatmentgroup，including60patientswithDR，wastreatedwithJiangtangreingmuCapsulesfor6months，andthentheindexes，includingTCMsyndromemanifestations，bloodsugarlevelandsecurityindexes，werecomparedbeforeandafterthetreatment．Thecontrolgroup，including60patients，wastreatedwithYikaifor6monthsandthenitwascomparedwiththetreatmentgroupinfundusretinopadiy．ResultInthetreatmentgrouptheTCMsyndromemanifestitionswererelieved．thecomparisonofintegralbeforeandafterthetreatmentwasP<0．01．ThereliefoffundusrefiuopathyinthetreatmentgroupWaSbetterthanthatofthecontrolgroup(P